Nucleation and Growth Inhibitors of Calcium Oxalate Crystallization
Inhibitors are though to act by influencing one or more of the three basic mechanisms of stone development, namely nucleation, growth, and aggregation or by influencing urine supersaturation (1). The aim of the present study was to examine the inhibitory activity of a number of potential inhibitors of calcium-oxalate crystallization and to characterize such inhibition in terms of nucleation and/or growth.
KeywordsHyaluronic Acid Methylene Blue Chondroitin Sulphate Calcium Oxalate Calcium Oxalate Monohydrate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
B Finlayson, Renal lithiasis in review, Urol. Clin. North America
1: 181 (1974).Google Scholar
JR Burns and B Finlayson, A proposal for a standard reference artificial urine in in vitro urolithiasis experiments, Invest. Urol.
18: 167 (1980).PubMedGoogle Scholar
PC Hallson and AG Rose, A new urinary test for stone activity, Br. J. Urol.
50: 442 (1978).PubMedCrossRefGoogle Scholar
GW Drach, AD Randolph, and JD Miller, Inhibition of calcium oxalate dihydrate crystallization by chemical modifiers: I. pyrophosphate and methylene blue, J. Urol.
119: 99 (1978).PubMedGoogle Scholar
SG Welshman and MG McGeown, A quantitative investigation on the growth of calcium oxalate crystals on potential inhibitors, Br. J. Urol.
44: 677 (1972).PubMedCrossRefGoogle Scholar
H Tiselius, Inhibition of calcium oxalate crystal growth in urine during treatment with allopurinol, Br. J. Urol.
52: 189 (1980).PubMedCrossRefGoogle Scholar
WG Robertson, M Peacock, and B Nordin, Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro, Clin. Chim. Acta
43: 31 (1973).PubMedCrossRefGoogle Scholar
© Springer Science+Business Media New York 1989